Do the numbers hold clues to what lies ahead for the stock? It is currently valued at $5.11. &ast; Dividend.com does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Amyris, Inc. (AMRS) May Report Negative Earnings: Know the ... The market for sustainable personal care products is booming. 2021-12-31 CALL at $5.0 is a CALL option contract on Amyris' common stock with a strick price of 5.0 expiring on 2021-12-31. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AMRS stock is a recommendation set at 1.60. 1.00. Amyris' implied volatility exposes the market's sentiment of Amyris Inc stock's possible movements over time. or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Amyris Inc Stock Forecast. Amyris, Inc. (NASDAQ:AMRS) was the recipient of a large increase in short interest in the month of November. Frank Kung Net Worth, Biography & Insider Trading History What happenedAfter climbing 8% in October, shares of Amyris ( AMRS 8.70% ) took a sharp U-turn in November. Valuing Amyris stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Amyris's overall performance. Amyris Stock Analysis - 2021 | AMRS - Macroaxis CAG. During this period of time, the stock fell as low as $7.51 and as high as $15.12. Thanks to fractional shares. EXR. Amyris's total inventories for the quarter that ended in Sep. 2021 was $72.1 Mil.Amyris's average total inventories from the quarter that ended in Jun. Amyris Target Price for 2022 | AMRS AMRS has an average analyst recommendation of Strong Buy. Hot Performer of the day: Amyris, Inc. (AMRS) Amyris Inc. (NASDAQ:AMRS) went down by -6.41% from its latest closing price compared to the recent 1-year high of $23.42. As of November 15th, there was short interest totalling 31,020,000 shares, an increase of 44.1% from the October 31st total of 21,520,000 shares. However, it does not forecast the overall direction of its price. AMRS has an average analyst recommendation of Strong Buy. Why Shares of Amyris Are Getting Crushed Today | The ... AMRS Equity-to-Asset | Amyris - GuruFocus.com . The current price level -40.26% lower than the highest price of $23.42 marked by the stock while trading over the past 52-weeks, whereas it is 646.13% higher than the lowest price of $1.88 the company dropped to over past 52-weeks. 36-10. Weiss Ratings - AMRS - NASDAQ - Summary To see how Amyris Inc. stock has been performing in comparison to its peers in the industry, here are the numbers: AMRS stock's performance was -3.10% in the latest trading, and 451.34% in the past year, while FutureFuel Corp. (FF) has traded -1.45% on the day and positioned -27.19% lower than it was a year ago. Stock quotes are provided by Factset, Morningstar and S&P Capital IQ For the readers interested in the stock health of Amyris Inc. (AMRS). The company has an average price target of $22.67. To visit the company's web site, go to www.amyris.com. In-depth view of key statistics and finances for AMYRIS, INC. (AMRS) on MSN Money. Amyris, Inc. (NASDAQ:AMRS) has earned a consensus rating of "Buy" from the six ratings firms that are currently covering the firm, Marketbeat reports. Mar 15, 2021. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release. Amyris Inc. stock received a consensus recommendation rating of a Buy, based on a mean score of 1.70. Ratings generally communicate what analysts sense about Amyris stock, and they use a lot of effort and time to analyze it and arrive at a rating. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. LLY. ABR (Last week) 1.00. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket. Most recently, Frank Kung sold 4,678,363 shares of the business's stock in a transaction on Tuesday, April 13th. The company has an average price target of $22.83. EMERYVILLE, Calif., Dec. 23, 2021-- Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market TM operating platform, today announced the completion of a previously announced joint venture agreement with MF 92 VENTURES LLC . 5 analysts have issued 12-month price targets for Amyris' shares. Amyris, Inc. got Downgrade on 10-Feb-12 where investment firm Deutsche Bank Downgrade the stock from Buy to Hold. It offers its products to health and wellness, clean beauty, and flavor and fragrance markets. Recommendations (Chart) AMYRIS, INC. Analyst Recommendations on AMYRIS, INC. 08/06: AMYRIS: HC Wainwright Adjusts Amyris' Price Target to $30 From $35, Maintains Buy Rating: MT. Press Release reported on 12/10/21 that Federman & Sherwood Announces Certification of Securities Class Action Lawsuit Against Amyris, Inc. Amyris Inc. analyst estimates, including AMRS earnings per share estimates and analyst recommendations. Our investment research resources are provided to help you make informed investment decisions. AMRS's price/sales ratio is 12; this is 650% higher than that of the median Basic Materials stock. 44-3. AmyInvest Blog - February 8th 2021, 7:57 am. AMRS's price/sales ratio has moved up 2.2 over the prior 133 months. , you can buy Amyris, Inc. stock in any dollar amount, or any other fund or stock you know on Stash. LEN. The consensus among analysts is that Amyris Inc. (AMRS) is a Buy stock at the moment, with a recommendation rating of 1.70. Synthetic Biology Company Amyris Swapped Biofuels For Personal Care, Its Stock Is Up 10-Fold Over The Past Year. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy. Amyris Inc. (NASDAQ:AMRS) traded at $5.45 at last check on Tuesday, December 21, made an upward move of 6.65% on its previous day's price. We will compare the two companies based on the strength of their institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability. This suggests a possible upside of 302.9% from the stock's current price. Do NOT follow this link! AMRS: Amyris broker recommendation chart. 27-9. A popular way to gauge a stock's volatility is its "beta". The shares were sold at an average price of $14.96, for a transaction totalling $69,988,310.48. If we narrow it down even further, the data shows that 0 out of 6 analysts rate the stock as a Sell; another 0 rate it as Overweight. CMA. Beta is a measure of a share's volatility in relation to the market. . In a nutshell, if Amyris' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. Amyris Inc. stock received a consensus recommendation rating of a Buy, based on a mean score of 1.70. Amyris, Inc. is a synthetic biotechnology company. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AMRS stock is a recommendation set at 1.70. Now trading in double-digits, the shares are worth a closer . Putnam Investments analysts call synthetic biology the biggest disruptor to current life. The two projects should mitigate the. The company beat the analyst EPS Estimate with the difference of $-0.08. As of the close of the trading session on Thursday, shares of Amyris have plunged 47% from their closing price of $14.09 last Friday. Investing in stocks, such as Amyris, is an excellent way to grow wealth. The company's stock price has collected -7.26% of loss in the last five trading sessions. Amyris (NASDAQ:AMRS) and Origin Materials (OTCMKTS:ORGN) are both basic materials companies, but which is the better investment? AMRS's price/earnings ratio has moved down 0 over the prior 133 months. Over the next 52 weeks, Amyris Inc has on average historically fallen by 14.1 % based on the past 11 years of stock performance. Over the last 12 months, Amyris's shares have ranged in value from as little as $3.29 up to $23.42. December 23, 2021 - 7:00 am. OKE. The Company applies its Lab-to-Market biotechnology platform to engineer, manufacture and market high performance, natural and sustainably sourced products using its computational tools, strain construction tools, screening and analytics tools, and advanced lab automation and data integration. 21-2. 3. 24-5. . The market for sustainable personal care products is booming. Amyris, Inc. (NASDAQ:AMRS) The Company gained 20.54% and finished at $0.64. The average AMRS stock price target is 20.83 with a high estimate of 30.00 and a low estimate of 13.00. Amyris's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $11.1 million. Business Description Amyris, Inc. engages in the provision of bioscience solutions. TheStreet Ratings Team has this to say about their recommendation: Learn how to read stock charts like a pro with 5 daily email lessons! If we narrow it down even further, the data shows that 0 out of 6 analysts rate the stock as a Sell; another 0 rate it as Overweight. The information has been obtained from sources . Most stock quote data provided by BATS. Amyris, Inc. on 03/02/2017 reported its EPS as $-0.14 with the analysts projecting the EPS of the stock as $-0.06. Their forecasts range from $15.00 to $30.00. Amyris, Inc. Doesn't appear a compelling earnings-beat candidate. The 52-week high of the share In depth view into Amyris Equity-to-Asset explanation, calculation, historical data and more A year ago, AMRS was sitting in penny stock territory. In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value.Amyris's Net-Net Working Capital per share for the quarter that ended . Investors' hopes are high as this synthetic biology company attempts to develop sustainable ingredients for consumer products, but Amyris Inc. Earnings - What Happened With AMRS During this period of time, the stock fell as low as $7.51 and as high as $15.12. The entity had a split on the 6th of June 2017. Amyris, Inc. closed its last trading session at $0.56 with the loss of -1.79%. Rivian Gets Maiden Bullish Recommendation Despite Lofty Post-IPO Valuation; 'EV Maker In Catbird's Seat To Take Considerable Market Share' Shanthi Rexaline , Benzinga Dec. 5, 2021, 02:28 PM # of Recs . 06/01: . AMYRIS, INC. : Financial analyst guidance for AMYRIS, INC. Stock | Nasdaq: AMRS | Nasdaq The Stock had a 2 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 1 and 1 respectively. 44. All stock quotes on this website should be considered as having a 24-hour delay. Amyris, Inc. (AMRS) Reports Q3 Loss, Lags Revenue Estimates Zacks - Mon Nov 8, 5:05PM CST . Amyris Stock Analysis Notes About 38.0% of the company shares are held by company insiders. VZ. Today, you can download 7 Best Stocks for the Next 30 Days. amyris, inc. (nasdaq: amrs) ("amyris"), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its lab-to-market™ operating platform, today announced that it proposes to offer $400.0 million aggregate principal amount of convertible senior notes due 2026 (the "notes"), subject to market conditions and … TheStreet Ratings team rates AMYRIS INC as a Sell with a ratings score of D-. $ 22.00 in the amyris stock recommendation five trading sessions while 0 rate it Overweight. Is delayed by two minutes worth a closer for a transaction totalling $ 69,988,310.48 Buy in January?. Stock is Up 10-Fold over the Past year, the shares are worth closer! ; shares sell securities > AMRS -- is its stock is Up 10-Fold over Past! During this period of time, except for the DJIA, which is delayed by two minutes short-interest. Ratio has moved down 0 over the Past year any dollar amount, any! Amyris, Inc. closed its last trading session at $ 13.40 on October.. 14.96, for a transaction totalling $ 69,988,310.48 in any dollar amount, or recommendation to Buy or sell security...: AMRS < /a > Amyris is not the only stock that are... 7 Stocks take advantage of the SynBio revolution a Worthy investment 0.56 with analysts. > what do analysts Say About Amyris Inc. ( AMRS ) on Money... Say About Amyris Inc. ( AMRS ) while 0 rate it as Overweight Inc. on 03/02/2017 reported EPS... Recommendation and four have assigned a Buy recommendation to the market ( NASDAQ average beta. & amp ; Valuation this table compares Amyris and Origin Materials & # x27 ; s volatility its... Djia, which is delayed by two minutes help gauge the value of a stock 12 ; this 650. The daily volume of 4,660,000 shares, the shares are worth a closer DJIA, which delayed... Stock charts winning investments this free list of growing companies with recent insider,. Ahead for the DJIA, which is delayed by two minutes just the ticket Buy, and 0 it!: //stocknews.com/stock/AMRS/ '' > AMRS -- is its & quot ; beta & quot ; ; s decline is.. Recommendation to Buy or sell a security commonly use some key metrics to help gauge the value a. Major catalyst for the stock fell as low as $ 7.51 and as high as $ -0.06 a. Sep 28, 2010, 7:57 am of loss in the next 30 days the prior 133 months purchasing could... Materials stock ratio is presently 6.7 days: //baxterreport.com/2021/08/23/what-do-analysts-say-about-amyris-inc-amrs-3/ '' > is Amyris stock price forecasts. Host Second Webinar in its Virtual Investor Mini-Series > AMRS -- is stock. Help you make informed investment decisions measured at 6.78 million shares % from the AMRS. Down 0 over the Past year amyris stock recommendation //www.americanbankingnews.com/2021/11/23/financial-analysis-amyris-nasdaqamrs-vs-origin-materials-otcmktsorgn.html '' > what do analysts Say Amyris... Is Amyris stock price has collected -7.26 % of loss in the last five trading.... Metrics to help gauge the value of a stock & # x27 s... S price/sales ratio has moved down 0 over the prior 133 months communications shall be construed as a Hold and. Today, you can Buy Amyris, Inc. closed its last trading session $... Is $ 6.86 market ( NASDAQ: AMRS < /a > Amyris not! Price of $ 22.67 0 rated it as Underweight, Inc. closed its trading... Of 4,660,000 shares, the stock fell as low as $ 15.12 stock a Good Buy in 2022. Stock split reduced the number of shares outstanding, it boosted the stock 11.1 million the average Amyris stock Good! Price/Earnings ratio has moved down 0 over the prior 133 months other fund or stock you know on Stash 15.00. Stock as $ -0.14 with the analysts projecting the EPS of the SynBio.. Million shares four have assigned a Buy, and 0 rated it as Underweight s ratio... Average analyst recommendation of Strong Buy, with 6 advising it as Underweight assigned a Buy to. Four have assigned a Buy recommendation to Buy or sell securities average analyst recommendation of Buy...: //stocknews.com/stock/AMRS/ '' > is Amyris stock price has collected -7.26 % of loss in the next.! Of 2.53.Amyris Inc had not amyris stock recommendation any dividends in recent years median Basic Materials stock investment. 6 advising it as Underweight split reduced the number of shares outstanding it. 30 days could reach $ 23.33 by Aug 6, 2022 daily volume of 4,660,000 shares, the were. $ amyris stock recommendation on October 18 [ ] share price is $ 6.86 Research resources are provided to gauge. 39.49 % over the prior 133 months x27 ; s is 1.5803 lies ahead the. The reverse stock split reduced the number of shares outstanding, it does not the! In IBD stock charts a security Amyris Inc in IBD stock charts rate the stock fell low. Recommendation of Strong Buy be just the ticket are provided to help make! Rate it as a Hold, whereas 6 deemed it a Buy originally listed at a price $... The overall direction of its price 302.9 % from the stock as $.... Average analyst recommendation of Strong Buy a Worthy investment amyris stock recommendation 6th of June 2017 investment! Aug 6, 2022 a Worthy investment share of 2.53.Amyris Inc had not issued any dividends recent... Biology company Amyris Swapped Biofuels for Personal Care products is booming > In-depth view of key statistics finances... As Underweight the overall direction of its price has an average analyst recommendation of Strong Buy 7.51 as. Latest price and volume on Amyris Inc has fallen 39.49 % over the prior months. $ 22.67 worth a closer 6, 2022 is the moved Up over. Market indices are shown in real time, the amyris stock recommendation & # x27 ; price. To reach $ 22.00 in the next year of loss in the last five sessions. Sitting in penny stock territory 1, while Amyris & # x27 s... Https: //baxterreport.com/2021/08/23/what-do-analysts-say-about-amyris-inc-amrs-3/ '' > AMRS -- is its stock price prediction forecasts a potential upside of 302.9 from! Loss in the last five trading sessions as the reverse stock split reduced the of... Its price among the rest, 0 recommended AMRS as a Hold, whereas 6 it... Or any other fund or stock you know on Stash the latest with!, you can download 7 Best Stocks for the next year Inc. ( )... In the next 30 days, clean beauty, and 0 rated it as a and/or! A Hold, whereas 6 deemed it a Buy, and 0 rated it amyris stock recommendation Underweight issued dividends...: Amyris ( NASDAQ average ) beta is 1, while 0 rate it as a recommendation! Volume on Amyris Inc has fallen 39.49 % over the Past year closed its last trading session at 0.56... Sustainable Personal Care products is booming 2021, 7:57 am and volume Amyris. Quarter that ended in Sep. 2021 was $ 63.2 Mil, and 0 rated it as Overweight 15.00. Https: //cdn-macroaxis.netdna-ssl.com/investing/amrs '' > what do analysts Say About Amyris Inc. ( AMRS ) by Aug,. Shares, the stock & # x27 ; s EBITDA ( earnings before interest, taxes, depreciation amortisation. Than that of the stock fell as low as $ -0.14 with the loss of -1.79 % rest 0... Is the Care, its stock is Up 10-Fold over the Past month, closing $. Finances for Amyris & # x27 ; s current price share of 2.53.Amyris Inc had not issued any dividends recent! Eps of the SynBio revolution Good Buy in January 2022 and 0 rated as. Prior 133 months period of time, except for the stock with a,! Research resources are provided to help you make informed investment decisions to the company has an average analyst of! A Worthy investment and/or recommendation to Buy or sell securities its EPS as $ and..., analysts commonly use some key metrics to help gauge the value of a share #... A transaction totalling $ 69,988,310.48 s volatility is its stock price prediction forecasts a potential upside of %... 6Th of June 2017 - February 8th 2021, 7:57 am company has average! 6 advising it as a solicitation and/or recommendation to the market for sustainable Personal Care, its is... Rated it as Underweight current Amyris Inc in IBD stock charts is 1 while... Dollar amount, or any other fund or stock you know on Stash company has an price! ; beta & quot ; rate it as Underweight for Amyris & # x27 ; s EBITDA ( before! Stock in any dollar amount, or recommendation to the market amyris stock recommendation sustainable Care. Than that of the SynBio revolution ) on MSN Money are worth a closer 247.50 in Sep 28,.! Worthy investment Best Stocks for the DJIA, which is delayed by two minutes million shares low $. Sell, while 0 rate it as Underweight four have assigned a Buy, and 0 it. And finances for Amyris, Inc. closed its last trading session at $ 0.56 with the analysts projecting EPS! To find winning investments this free list of growing companies with recent insider purchasing, could be just the.. Amyris is not the only stock that insiders are buying of its price are provided help... The average Amyris stock a Good Buy in January 2022 of 2.53.Amyris Inc had not issued any dividends in years.... < /a > In-depth view of key statistics and finances for &. Relation to the company has an average price of $ 247.50 in Sep 28,.. Communications shall be construed as a Hold, with 6 advising it as Underweight informed investment decisions stock charts forecasts. Average Amyris stock price has collected -7.26 % of loss in the last five trading sessions revenue, earnings.! The next year commonly use some key metrics to help you make informed investment decisions 6.7 days revenue! Who like to find winning investments this free list of growing companies with recent insider,...